METHOD TO ESTIMATE THE AGE OF TISSUES AND CELL TYPES BASED ON EPIGENETIC MARKERS

• US 20160222448A1
• Filed: 09/29/2014
• Published: 08/04/2016
• Est. Priority Date: 09/27/2013
• Status: Active Application

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Horvath, Stefan
• Application Number:
  US15/025,185
• Publication Number:
  US 20160222448A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: C12Q 2600/154 Methylation markers
• CPC Class Codes: G01N 2440/12 alkylation, e.g. methylation, (iso-)prenylation, farnesylation
• CPC Class Codes: G01N 2800/105 Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone

Abstract

A method for determining the age of a biological sample comprising measuring a methylation level of a set of methylation markers in genomic DNA of the biological sample. An age of the biological sample is determined with a statistical prediction algorithm, comprising (a) obtaining a linear combination of the methylation marker levels, and (b) applying a transformation to the linear combination to determine the age of the biological sample.

Claims

1. A method for determining the age of a biological sample comprising:

measuring a methylation level of a set of methylation markers in genomic DNA of the biological sample; and

determining an age of the biological sample with a statistical prediction algorithm, comprising (a) obtaining a linear combination of the methylation marker levels, and (b) applying a transformation to the linear combination to determine the age of the biological sample.

2. The method of claim 1, wherein the biological sample is a blood, saliva, epidermis, brain kidney or liver sample.

3. The method of claim 1, wherein biological sample is a blood or saliva sample.

4. The method of claim 1, wherein the set of methylation markers comprises at least 4 methylation markers.

5. The method of claim 4, wherein the set of methylation markers comprises a marker in at least one of the NHLRC1, GREM1, SCGN or EDARADD genes.

6. The method of claim 4, wherein the set of methylation markers comprises a marker in the SCGN and EDARADD genes.

7. The method of claim 4, wherein the set of methylation markers comprise the CpG positions corresponding to Illumina™

probe IDs cg22736354 (SEQ ID NO;

     158), cg09809672 (SEQ ID NO;

     252), cg21296230 (SEQ ID NO;

     354), and cg06493994 (SEQ ID NO;

     46).

8. The method of claim 1, wherein the set of methylation markers are selected from markers in the genes of Table 3.

9. The method of claim 8, wherein the set of methylation markers comprise markers in each of the genes of Table 3.

10. The method of claim 8, wherein the set of methylation markers are selected from the CpG positions of Table 3.

11. The method of claim 10, wherein the set of methylation markers comprise each of the CpG positions of Table 3.

12. The method of claim 1, wherein the age of an individual is determined based on the age of the biological sample.

13. The method of claim 1, wherein measuring a methylation level of a set of methylation markers comprises treatment of genomic DNA from the sample with bisulfite to convert unmethylated cytosines of CpG dinucleotides to uracil.

30. The method of claim 1, wherein the age of an individual is determined based on the age of the biological sample.

31. The method of claim 1, the method of claim 16 further comprising reporting the age of the sample.

32. The method of claim 31, wherein said reporting comprises preparing a written or electronic report.

14. A kit comprising probes for detecting methylation markers comprising the CpG positions corresponding to Illumina™

probe IDs cg22736354, cg09809672, cg21296230, and cg06493994.

15. The kit of claim 14, further comprising probes for detecting methylation markers comprising each of the CpG positions of Table 3.

16. A method for determining an age of a biological sample comprising:

selectively measuring the methylation levels of a set of methylation markers in genomic DNA of the biological sample, said set of methylation markers comprising markers in at least 6 of the genes listed in Table 3; and

determining the age of the sample based on said methylation levels.

17. The method of claim 16, wherein the biological sample is a solid tissue, blood, urine, fecal or saliva sample that comprises genomic DNA.

18. The method of claim 16, wherein the biological sample is a sample comprising tissue culture cells or pluripotent stem cells.

19. The method of claim 16, wherein determining the age of the biological sample comprises applying a statistical prediction algorithm to the measured methylation marker levels.

20. The method of claim 19, wherein determining the age of the biological sample comprises (a) obtaining a linear combination of the methylation marker levels, and (b) applying a transformation to the linear combination to determine the age of the biological sample.

21. The method of claim 16, wherein the set of methylation markers comprise markers in at least 15 of the genes listed in Table 3.

22. The method of claim 21, wherein the set of methylation markers comprising markers in at least 30 of the genes listed in Table 3.

23. The method of claim 21, wherein the set of methylation markers comprising markers in at least 6 of the genes listed in Table 4.

24. The method of claim 16, wherein the set of methylation markers comprising markers in at least 6 of the genes listed in Table 5.

25. The method of claim 16, wherein the set of methylation markers comprising markers in at least 6 of the genes listed in Table 6.

26. The method of claim 16, wherein the set of methylation markers comprising markers in at least 3 of the genes listed in Table 7.

27. The method of claim 23, wherein the set of methylation markers comprise markers in each of the genes of Table 3.

28. The method of claim 27, wherein the set of methylation markers comprises methylation markers at the CpG positions of Table 3.

29. The method of claim 16, wherein the set of methylation markers comprise markers in the NHLRC1, GREM1, SCGN or EDARADD genes.

33. The method of claim 16, wherein measuring a methylation level of a set of methylation markers comprises treatment of genomic DNA from the sample with bisulfite to convert unmethylated cytosines of CpG dinucleotides to uracil.

34. A tangible computer-readable medium comprising computer-readable code that, when executed by a computer, causes the computer to perform operations comprising:

a) receiving information corresponding to methylation levels of a set of methylation markers in a biological sample, said markers comprising markers in at least 6 of the genes listed in Table 3; and

b) determining the age of the biological sample by applying a statistical prediction algorithm to the measured methylation marker levels.

35. The tangible computer-readable medium of claim 34, determining the age of the biological sample further comprises comparing the measured methylation marker levels to reference marker levels.

36. The tangible computer-readable medium of claim 34, wherein the reference levels are stored in said tangible computer-readable medium.

37. The tangible computer-readable medium of claim 34, wherein the receiving information comprises receiving from a tangible data storage device information corresponding to the methylation levels of the set of methylation markers in the biological sample.

38. The tangible computer-readable medium of claim 34, further comprising computer-readable code that, when executed by a computer, causes the computer to perform one or more additional operations comprising:

sending information corresponding to the methylation levels of the set of methylation markers in the biological sample to a tangible data storage device.

39. The tangible computer-readable medium of claim 34, wherein the receiving information further comprises receiving information corresponding to methylation levels of a set of methylation markers in a biological sample, said markers comprising markers in at least 10, 15, 20, 25, 30, 35, 40, 45, or 50 of the genes listed in Table 3.

40. The tangible computer-readable medium of claim 34, wherein determining the age of the biological sample comprises applying a linear regression model to predict sample age based on a weighted average of the methylation marker levels plus an offset.

41. A method for determined the age of an individual comprising:

collecting a tissue sample from an individual;

extracting genomic DNA from the collected tissue sample;

measuring a methylation level of a methylation marker on the genomic DNA; and

determining an age of the individual with a statistical prediction algorithm, wherein the statistical prediction algorithm is applied to the measured methylation level to determine the age of the individual.

42. The method of claim 41 wherein the methylation marker is a CpG methylation marker for a NHLRC1, GREM1, SCGN or EDARADD gene.

43. The method of claim 42 wherein the methylation level of at least one of the NHLRC1, GREM1, SCGN or EDARADD gene is measured and the age of the individual is determined by applying the statistical prediction algorithm to the at least one measured methylation level.

44. The method of claim 43 wherein the methylation levels of the EDARADD and SCGN gene are measured and the age of the individual is determined by applying the statistical prediction algorithm to the two measured methylation levels.

45. The method of claim 41 wherein the methylation marker is a cytosine marker corresponding to Illumina™

probe IDs cg22736354, cg09809672, cg21296230, and cg06493994.

46. A method for determined the age of the brain of an individual comprising:

collecting a blood or saliva tissue sample from an individual;

extracting genomic DNA from the collected blood or saliva tissue sample;

measuring a methylation level of a methylation marker on the genomic DNA, wherein the methylation marker is a CpG methylation marker for a NHLRC1, GREM1, SCGN or EDARADD gene; and

determining an age of the brain of the individual with a statistical prediction algorithm, wherein the statistical prediction algorithm is applied to the measured methylation level to determine the age of the individual.

47. A method for observing the health of an individual comprising:

collecting a tissue sample from an individual;

extracting genomic DNA from the collected tissue sample;

measuring a methylation level of a methylation marker on the genomic DNA;

determining a biological age of the individual with a statistical prediction algorithm, wherein the statistical prediction algorithm is applied to the measured methylation level to determine the biological age of the individual; and

comparing the biological age of the individual to a chronological age of the individual.

48. The method of claim 47 wherein a biological age that is greater than the chronological age of the individual is an indication of age acceleration of the individual.

49. The method of claim 47 wherein a first tissue sample and a second tissue sample are collected from the individual and the biological age of the first tissue sample is compared to the biological age of the second tissue sample.

50. The method of claim 49 wherein a biological age of the first tissue sample that is greater than the biological age of the second tissue sample is an indication that the first tissue sample is diseased.